Medlab Dubai : JIEZLAB Diagnostics’ Spectacular Debut in Early 2025
Release time:
2025-02-07
From February 3 to February 6, 2025, Medlab Middle East was held at the Dubai World Trade Centre, attracting global industry experts. As a top medical laboratory services platform, the exhibition provided invaluable opportunities for exhibitors to explore cutting-edge industry trends and business prospects.
At the event, JIEZLAB Diagnostics showcased two eye-catching models: JIE-100 Microfluidic Clinical Chemistry Analyzer and JIE-200 Microfluidic Emergency Immunoassay Analyzer. These two products utilize microfluidic technology aiming to provide rapid and accurate diagnostic results for clinical diagnosis.
Microfluidic Emergency Immunoassay Analyzer attracted significant attention from European clients for high-sensitivity cardiac troponin T (hs-cTnT) detection capability. It features flexible cardiac panel combinations, and supports simultaneous multi-sample testing for 1 to 6 different assays, delivering results in just 12 minutes. This device’s precision and efficiency attracted a lot of experts and customers for in-depth consultations.
Meanwhile, the Microfluidic Clinical Chemistry Analyzer stood out for its versatile test panels tailored to clinical needs. It offers flexible assay combinations and supports the analysis of both blood and urine samples, making it highly adaptable to various medical settings. It garnered strong interest from customers worldwide.







JIEZLAB Diagnostics received remarkable feedback from both experts and customers for outstanding performance, precise diagnostic results, and clinically optimized design.
In 2025, JIEZLAB Diagnostics remains committed to medical innovation, keeps pace with global technology development footprint and looks forward to collaborating with global partners to achieve mutual success !
Related News